Humacyte Files 2025 Proxy Statement
Ticker: HUMAW · Form: DEF 14A · Filed: Apr 29, 2025 · CIK: 1818382
| Field | Detail |
|---|---|
| Company | Humacyte, Inc. (HUMAW) |
| Form Type | DEF 14A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
Related Tickers: HUMA
TL;DR
Humacyte's proxy statement is in, annual meeting June 10th - shareholders vote on company direction.
AI Summary
Humacyte, Inc. filed its definitive proxy statement on April 29, 2025, for its annual meeting on June 10, 2025. The company, formerly Alpha Healthcare Acquisition Corp., is seeking shareholder approval for matters related to its business operations and corporate governance. The filing covers the fiscal year ending December 31, 2024.
Why It Matters
This filing outlines key proposals and information shareholders will vote on, impacting the company's future direction and governance.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Players & Entities
- Humacyte, Inc. (company) — Registrant
- Alpha Healthcare Acquisition Corp. (company) — Former company name
- June 10, 2025 (date) — Annual meeting date
- April 29, 2025 (date) — Filing date
- December 31, 2024 (date) — Fiscal year end
FAQ
What is the purpose of this DEF 14A filing?
The purpose of this filing is to provide shareholders with information and solicit their votes for the annual meeting of shareholders scheduled for June 10, 2025.
When is Humacyte, Inc.'s annual meeting of shareholders?
Humacyte, Inc.'s annual meeting of shareholders is scheduled for June 10, 2025.
What was Humacyte, Inc.'s former name?
Humacyte, Inc.'s former name was Alpha Healthcare Acquisition Corp., with a name change effective July 16, 2020.
What fiscal year does this proxy statement cover?
This proxy statement covers the fiscal year ending December 31, 2024.
On what date was this definitive proxy statement filed with the SEC?
This definitive proxy statement was filed with the SEC on April 29, 2025.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 29, 2025 regarding Humacyte, Inc. (HUMAW).